← FDA Drug Approvals (Drugs@FDA)
KAFOCIN
NDA · New Drug Application · Sponsor: LILLY · Approved 1970-06-12
Drug application
- FDA Application #
NDA050219- Application type
- New Drug Application
- Brand name
- KAFOCIN
- Generic name
- Cephaloglycin
- Active ingredients
- CEPHALOGLYCIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- LILLY
- First approval
- 1970-06-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown